Psoriasis


Taking on PsO With a New Photopharmaceutical Compound
February 3, 2025

Exploring NF-kB c-Rel’s Role in Psoriasis
February 3, 2025



Deucravacitinib Hits Primary Endpoints in Two Phase 3 PsA Studies
December 23, 2024

U.S. FDA Approves Celltrion’s STELARA Biosimilar
December 18, 2024


Ultraprocessed Foods May Up Risk for Psoriasis
November 27, 2024

Mindera Health, NPF Partner to Advance Precision Medicine in Psoriasis
November 19, 2024


Johnson & Johnson Debuts Tremfya Clearance Photo Library
October 25, 2024